|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,135.00 TWD | -1.30% |
|
-9.92% | +167.88% |
| 07-22 | PharmaEssentia Seeks Macau Nod to Expand Besremi Use for Rare Blood Cancer | MT |
| 07-09 | PharmaEssentia Swings to Profit in May as Revenue Balloons 108% | MT |
| Market Cap | 468B 14.46B 12.7B 11.81B 10.84B 20.37B 1,393B 20.68B 140B 54.81B 685B 54.3B 53.13B 2,368B | P/E 2026 * |
43.6x | P/E 2027 * | 31.7x |
|---|---|---|---|---|---|
| Enterprise Value | 441B 13.64B 11.98B 11.14B 10.23B 19.21B 1,314B 19.51B 132B 51.7B 646B 51.22B 50.11B 2,233B | EV / Sales 2026 * |
17.6x | EV / Sales 2027 * | 12.5x |
| Free-Float |
75.37% | Yield 2026 * |
0.08% | Yield 2027 * | 0.13% |
| 1 day | -1.30% | ||
| 1 week | -9.92% | ||
| Current month | -6.04% | ||
| 1 month | +14.98% | ||
| 3 months | +100.16% | ||
| 6 months | +109.84% | ||
| Current year | +167.88% |
| 1 week | 1,120 |  | 1,235 |
| 1 month | 1,032.2 | | 1,415.34 |
| Current year | 423.7 | | 1,415.34 |
| 1 year | 395.61 | | 1,415.34 |
| 3 years | 222.58 | | 1,415.34 |
| 5 years | 56.05 | | 1,415.34 |
| 10 years | 43.54 | | 1,415.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 01/01/2003 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 14/10/2015 |
Albert Qin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ching Liu Chan
CHM | Chairman | - | 01/09/2003 |
Cheng Ku Huang
BRD | Director/Board Member | - | - |
Chao Ho Chen
BRD | Director/Board Member | - | 30/06/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.30% | -9.92% | +160.67% | +284.37% | 14.64B | |
| -1.92% | -1.57% | +48.70% | +84.37% | 55.92B | |
| +0.93% | +7.22% | +64.67% | +63.56% | 56.67B | |
| -2.97% | -2.35% | -22.03% | -16.54% | 23.28B | |
| -0.46% | -1.29% | +3.28% | +422.58% | 23.28B | |
| -0.36% | -0.56% | +36.00% | -3.93% | 20.54B | |
| -1.34% | -0.63% | +29.60% | -32.53% | 17.78B | |
| -1.44% | -1.63% | +37.07% | +589.93% | 15.9B | |
| -0.50% | -0.98% | +23.62% | +178.38% | 13.99B | |
| -1.36% | +15.21% | +426.45% | +144.15% | 12.22B | |
| Average | -0.99% | +2.58% | +80.80% | +171.44% | 25.42B | |
| Weighted average by Cap. | -0.83% | +2.44% | +61.77% | +137.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 25.07B 775M 681M 633M 581M 1.09B 74.62B 1.11B 7.52B 2.94B 36.69B 2.91B 2.85B 127B | 34.57B 1.07B 938M 873M 801M 1.5B 103B 1.53B 10.36B 4.05B 50.59B 4.01B 3.92B 175B |
| Net income | 10.85B 336M 295M 274M 251M 473M 32.31B 480M 3.25B 1.27B 15.89B 1.26B 1.23B 54.92B | 14.97B 463M 406M 378M 347M 652M 44.57B 662M 4.49B 1.75B 21.91B 1.74B 1.7B 75.76B |
| Net Debt | -26.52B -820M -720M -670M -615M -1.15B -78.96B -1.17B -7.95B -3.11B -38.82B -3.08B -3.01B -134B | -34.73B -1.07B -943M -877M -805M -1.51B -103B -1.54B -10.41B -4.07B -50.82B -4.03B -3.94B -176B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | NT$1,135.00 | -1.30% | 1,580,118 |
| 23/07/26 | NT$1,150.00 | -2.54% | 2,928,191 |
| 22/07/26 | NT$1,180.00 | +0.43% | 2,030,357 |
| 21/07/26 | NT$1,175.00 | 0.00% | 2,044,851 |
| 20/07/26 | NT$1,175.00 | -1.67% | 2,926,691 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
Select your edition
All financial news and data tailored to specific country editions
